rBC2LCN lectin as a potential probe of early‐stage HER2‐positive breast carcinoma

The recombinant N‐terminal domain of BC2L‐C lectin (rBC2LCN) is useful for detecting not only human pluripotent stem cells but also some cancers. However, the cancer types and stages that can be detected by rBC2LCN remain unclear. In this study, we identified the human breast carcinoma subtypes and...

Descripción completa

Detalles Bibliográficos
Autores principales: Mawaribuchi, Shuuji, Haramoto, Yoshikazu, Tateno, Hiroaki, Onuma, Yasuko, Aiki, Yasuhiko, Ito, Yuzuru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7262912/
https://www.ncbi.nlm.nih.gov/pubmed/32237061
http://dx.doi.org/10.1002/2211-5463.12852

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7262912/
https://www.ncbi.nlm.nih.gov/pubmed/32237061
http://dx.doi.org/10.1002/2211-5463.12852

Ejemplares similares